Semaglutide & tirzepatide compounded versions are fading. Learn what patients should know about the GLP-1 shortage, safe brand-name options, and how DevotedDOc is helping.

You’ve heard the names: Ozempic, Wegovy, Mounjaro.
Lose weight fast. Suppress your appetite. Fix your metabolism.

Everywhere you look, new telehealth clinics are popping up offering overnight prescriptions and promising quick results. You’ve probably seen the ads, the influencers, the “get-skinny-fast” headlines.

Then came the shortages.
Then came the shutdowns.

Now? 

Thousands of patients are left confused, unmonitored, and asking: “What do I do next?”

Let’s break it down clearly, honestly, and from a physician who’s seen both sides.

First, What Are GLP-1s and Why Are They So Popular? 

GLP-1s are a class of medications originally designed for type 2 diabetes. But they’ve become the gold standard for medically assisted weight loss especially for patients struggling with:

• Obesity
• PCOS
• Insulin resistance
• High blood pressure
• Metabolic syndrome
   

Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) reduce appetite, slow digestion, and help regulate insulin all of which lead to significant, sustainable fat loss when used properly.

 Clinical trials have shown up to 22.5% total body weight loss with these medications, backed by real data not hype. 

Why Patients Turned to Compounded Versions

With supply issues and skyrocketing demand, many patients turned to compounded GLP-1s custom formulations made by specialty pharmacies during periods of FDA-declared shortages.

These versions were cheaper and easier to get. 

But here’s what many patients don’t know:

• Not all compounding pharmacies followed strict quality standards
• Some versions included research-grade ingredients or non-bioidentical salts (e.g., semaglutide sodium)
• Others lacked safety data, dosing reliability, or transparency

And now? As supply of the brand-name medications stabilizes, the legal window for compounding is closing.

Can You Still Get Compounded Semaglutide or Tirzepatide?

Not legally not really. 

In some corners of the internet, you’ll still see ads for “compounded semaglutide” or “tirzepatide + B12.”
But let’s be clear: for most patients and most pharmacies, those offers are no longer legal. 

When patients ask us about those options, we say:

“That’s a red flag and you may be left without a reliable treatment plan.”

• FDA guidance restricts compounding when a drug is no longer in shortage 
• Most reputable pharmacies have already stopped production, some are fighting big pharma. 
• Some providers continue to offer unauthorized or loosely regulated compounds and patients are being left vulnerable. 

If your “GLP-1” contains B12, claims to be semaglutide sodium, or comes from a provider who can’t name the pharmacy? That’s a red flag and  you might get left without a reliable treatment plan and potentially dangerous situation. 

What the FDA Has Said (And What’s Actually Changing)

When semaglutide and tirzepatide first went into FDA-declared shortage, the agency allowed compounding pharmacies to legally produce custom formulations under Section 503A of the Food, Drug, and Cosmetic Act. 

That was temporary……

As brand-name supply increases, the FDA has begun tightening enforcement, and drug manufacturers like Eli Lilly and Novo Nordisk have taken legal action to stop certain pharmacies from compounding unauthorized versions of their medications. 

Notable Developments:

• May 2023: The FDA warned consumers about pharmacies using unauthorized ingredients like semaglutide sodium or semaglutide acetate, which are not the same as FDA-approved semaglutide.
• 2024: Lilly and Novo Nordisk began filing lawsuits against compounding pharmacies and telehealth companies making unverified claims or selling unapproved formulations.
• Current Status: As the FDA removes semaglutide and tirzepatide from the official shortage list, most compounding will no longer be allowed even with additives like B12.

 Bottom line: If a provider is still selling “compounded GLP-1s,” they may be violating federal law and your treatment could be interrupted with zero warning. 

So Who Should You Be Wary Of?

The problem now isn’t the 503A/503B pros it’s the unlicensed, unverified “clinics” offering mystery versions of semaglutide or tirzepatide, often shipped from unknown pharmacies with no safety data.

Some are:

• Using research-grade peptides
• Mislabeling or diluting medications
• Adding inappropriate compounds (like “semaglutide + B12” without clinical basis)
• Or skipping any physician review entirely
   

These are the setups putting patients at risk.
Desperate people are being sold hope in a vial without a real care plan, side effect monitoring, or exit strategy.

What’s a 503A or 503B Pharmacy and Why It Matters

Not all compounding pharmacies are bad actors.
In fact, during the height of the shortage, many 503A and 503B pharmacies stepped up and filled a critical care gap offering patients access to GLP-1 medications that were otherwise impossible to find.

So here’s the breakdown:

503A Pharmacies

These are traditional compounding pharmacies that prepare medications based on individual prescriptions. 

They’re regulated by state boards of pharmacy and must follow USP guidelines for safety, sterility, and documentation.

503B Outsourcing Facilities

These are FDA-registered facilities that can manufacture larger batches of compounded medications and ship across state lines. They’re held to higher manufacturing standards and more rigorous FDA inspections. 

But as supply catches up and lawsuits fly, even these legit players are being forced to step back.

So What Can Patients Do Next?

This is where many patients feel lost. You’re trying to improve your health, you’re finally seeing results, and now the rug is being pulled out from under you.

You have options but only if you’re guided by someone who knows the landscape.

DevotedDOc’s Role: Be Your Guide 

We’re not here to scare you.
We’re here to help you make informed decisions.

Whether you’re switching from compounded semaglutide or starting your first GLP-1, 

DevotedDOC offers:

• Physician-led virtual evaluations
• Safe brand-name fulfillment via trusted pharmacy partners
• Insurance support or affordable cash-pay options
• Food tracking tools, journals, and ongoing clinical check-ins
• A real plan, designed by real doctors

 You deserve better than a black-market injection and a sales rep.
You deserve a partner in your care and we’re ready when you are. 

Talk to a licensed physician with experience not just a telemarketing clinic.
Switch to brand-name therapy through a pharmacy that complies with FDA guidance.
Ask for help with insurance pre-authorization if you may qualify based on BMI or comorbidities. 

Don’t trust anyone who won’t name the medication, dose, or pharmacy. Transparency is key…..

We’ve seen this before in medicine: high demand leads to low oversight.
Don’t become another patient left with no refill, no support, and no plan.

Final Word From the DOc

GLP-1 medications like semaglutide and tirzepatide aren’t just trends they’re tools. And like any tool, they only work when used with skill, experience, and a real plan.

At DevotedDOc, we cut through the confusion.
We guide you with facts, not fear.
We treat you like a patient, not a prescription.

Whether you’re just getting started or need help finding your next step after compounded meds we’ve got your back.

Because real medicine still exists.

And at DevotedDOc, it leads with you.

 Ready to take the next step with expert guidance?
Start your consult today 

— The DevotedDOc
Founder | Emergency Physician | Weight Loss Provider | Patient Advocate

Up Next: Wegovy, Ozempic, Mounjaro, or Zepbound Which One’s Best?

Think all GLP-1s are the same? Think again. We’re breaking down the differences between semaglutide vs. tirzepatide, brand names, side effects, outcomes, and which one delivers the biggest results.

That answer might surprise you—
but yes, there is a clear winner.
 

Stay tuned…….